Can a peptide store use Authorize.net?

SHORT ANSWER

A gateway account is not the decision that matters. Authorize.net describes itself as the technology in the middle; the merchant account that actually settles card sales is underwritten by an acquiring bank, and its underwriter reviews your industry. Whether a peptide store can process depends on that bank’s category policy and Visa’s acquirer rules, not on the gateway.

01 / THREE PARTIES

Gateway, merchant account, and acquirer are different things

Authorize.net’s own explainer lists the parties in a card sale: the customer, the merchant, the issuer, the acquirer, and the gateway. It describes the gateway as the piece that “sits in the middle” and “connects all the key players.” The acquirer is “the bank where you have your merchant account.”

Its pricing page draws the same line. A gateway is “the technology that securely transmits payment data”; a merchant account is “the bank account that holds your funds after a transaction is approved.” Two products, two decisions.

The distinction matters for a peptide seller because the gateway carries the data and the merchant account carries the risk. Only one of them has an underwriter.

02 / IN THEIR OWN WORDS

Authorize.net describes underwriting as the acquirer’s job

On the how-payments-work page, Authorize.net states: “When you apply for a merchant account, the acquirer’s underwriter takes a number of factors into account,” and the first factor listed is “Your industry.” The pricing FAQ repeats it: the underwriter “will look at your industry, your processing history (if any),” and creditworthiness.

Authorize.net sells two plans. “All-in-one” bundles a merchant account it helps arrange; “Gateway Only” connects to a merchant account you already hold “without replacing your existing account.” Under either plan, the page says a Merchant Service Provider moves the funds, and approval for the bundled account “could be as quick as one hour if the application is ‘auto-approved.’”

Neither page publishes a prohibited or restricted business list for the gateway itself. The site’s Terms of Use say that where they conflict with “the applicable Service Agreement, the latter shall govern,” and that service agreement is not posted publicly. So there is no Authorize.net page to quote that says peptides are in or out. The category decision sits with the acquirer.

03 / THE ACQUIRER’S RULES

The bank answers to Visa’s acquirer rules

Authorize.net is a Visa company, and the bank behind any merchant account it arranges operates under Visa’s acquirer requirements. Visa’s Online Pharmacy Guide for Acquirers (June 2016) states that Visa “requires that acquirers register with Visa Inc. to receive a High Brand-Risk Acquirer license” before boarding a card-not-present internet pharmacy merchant.

The same guide tells risk teams not to judge these merchants by dispute history: “the absence of an intellectual property violation or chargeback does not establish its legitimacy.” That is the bank’s instruction from the network, and it explains why a clean processing record does not settle the category question.

The guide is written for pharmacies, not peptides. It is cited here for what it shows about how acquirers are told to think: category first, evidence of legitimacy second, chargebacks last. A storefront that sells peptides with human-use context on the page is the kind of merchant that guidance was written to catch.

• The acquirer assigns the merchant category code, and Visa can require it to be corrected (see the merchant category codes guide).
• High brand-risk registration is the acquirer’s obligation, and it is a cost and a review burden the bank weighs before boarding.
• The gateway does not change any of this; it transmits whatever the merchant account is permitted to process.

04 / RESELLER CLAIMS

“Authorize.net accepts peptides” is half a sentence

Payment resellers and high-risk brokers often advertise Authorize.net integration as though the gateway were the approval. Read against Authorize.net’s own description, the claim only says the gateway can be connected to a merchant account. It says nothing about which acquirer will open that account for a peptide storefront, on what terms, or for how long.

The honest version of the sentence is: Authorize.net’s Gateway Only plan can sit in front of a merchant account from a bank that has agreed to board the business. Whether such a bank exists for a given storefront depends on the storefront, the bank’s category policy, and the network registration the bank must carry.

The same logic applies to any gateway. The three-party structure is not an Authorize.net quirk; it is how card processing works.

05 / BEFORE YOU APPLY

Make the underwriter’s first factor easy to answer

The underwriter looks at your industry first, and it reads your industry off your storefront. Product names, descriptions, imagery, bundled supplies, and testimonials are what a bank sees when it decides which category you are in. That review happens before, and independent of, any gateway setup.

• Confirm which merchant account will sit behind the gateway and which bank underwrites it.
• Ask that bank, not the gateway, whether research-use peptide sales are within its category policy.
• Review the storefront for human-use context before any application is filed.
• Keep the evidence of what was changed, so the application describes the business as it is.

See what a RUO Clear scan covers

QUESTIONS

Related questions

SOURCES

Sources cited

Each source is listed with its class so government authority, agency guidance, enforcement examples, and private policy are never blended into one rule.

RELATED GUIDES

Keep reading